Testing for infection with human immunodeficiency virus (HIV) shall be

Testing for infection with human immunodeficiency virus (HIV) shall be performed only under the following conditions: 1. No individual or agency shall perform screening tests or collect specimens for the performance of such tests without either the ability to perform appropriate confirmatory tests, such as fluorescent antibody, Western blot, or other tests accepted as confirmatory by the State Department of Health, or arrangements to have such confirmatory tests performed. 2. Individuals tested for HIV infection shall be notified of the results of the testing only upon completion of appropriate confirmatory or second level test such as fluorescent antibody, Western blot, or other tests accepted as confirmatory by the State Department of Health. 3. No testing shall be performed without appropriate post-test counseling of individuals tested. 4. All conditions stated above pertain to any brand of rapid HIV test. Exceptions: 1) “negative” rapid HIV test results may be provided directly to the patient. 2) provision of “preliminary positive” rapid HIV test results to the patient pending receipt of required confirmatory test results is permitted. Providers offering rapid HIV testing should receive specific pre- and post-test counseling training. It is preferred that the confirmatory test specimen collection occur immediately, but if that is not possible, every effort should be made to assure that the patient reports for confirmatory testing as soon as possible. 5. For all diagnosed cases of HIV infection, subsequent HIV-related serology results as defined shall be reported to the health department. Laboratories shall report each test result for the following required HIV-related serology: a. HIV viral load results, both detectable and undetectable b. CD4+ (T4) lymphocyte results of any value